Related Experiment Videos
The basic region/helix-loop-helix/leucine repeat transcription factor USF interferes with Ras transformation
C Aperlo1, K E Boulukos, P Pognonec
1Laboratoire de Biochimie, INSERM U273, Université de Nice, France.
European Journal of Biochemistry
|October 1, 1996
Summary
Upstream stimulatory factor (USF) does not cause cancer but inhibits Ras-driven cell transformation. This effect requires USF's DNA-binding activity, suggesting a role in cell growth control.
Area of Science:
- Molecular Biology
- Cellular Biology
- Oncology
Background:
- Upstream stimulatory factor (USF) belongs to the basic helix-loop-helix/leucine repeat transcription factor family.
- USF shares DNA-binding sequences with the myc oncogene and its DNA-binding domain is structurally similar to Max.
- USF heterodimerizes with FIP/USF2, a factor interacting with Fos, implicating USF in cell proliferation pathways.
Purpose of the Study:
- To investigate the role of Upstream stimulatory factor (USF) in cellular growth control.
- To determine if USF acts as an oncogene or influences Ras-driven transformation.
Main Methods:
- Investigated USF's effect on Ras-driven transformation.
- Assessed the role of USF's transactivating and DNA-binding domains in this effect.
- Compared the inhibitory effect of full-length USF with its minimal DNA-binding domain.
Main Results:
- Upstream stimulatory factor (USF) does not function as an oncogene.
- USF actively interferes with Ras-driven cell transformation.
- This inhibitory effect is dependent on USF's DNA-binding activity but independent of its transactivating domains.
- The minimal USF DNA-binding domain alone did not inhibit, and slightly enhanced, Ras transformation.
Conclusions:
- Upstream stimulatory factor (USF) plays a significant role in controlling cell growth and proliferation.
- USF exerts its regulatory function through both promoter sequence binding and protein-protein interactions.
- USF's inhibitory influence on Ras transformation highlights its complex role beyond simple oncogenic potential.